Abstract
Legend has it that the term claudication was given after the Roman Emperor Claudius, who would walk for a short distance, then stop and stand before he would start walking again. Etymologically, claudication is derived from the Latin verb claudicare, which means to limp. In 1858, Jean Martin Charcot described pain in the lower extremities resulting from arterial insufficiency. Intermittent claudication can inhibit walking, and cause limping due to ischemia of the lower extremity unilaterally or bilaterally. The most common cause of lower extremity ischemia is peripheral arterial disease of the major arteries supplying the legs and feet. Lower extremity ischemia may also progress to severe limb-threatening ischemia with symptoms and physical signs at rest as well. A detailed complete history should be obtained from every patient, middle-aged and the elderly, before the diagnosis of claudication is made. Vascular claudication under the age of 45 years is rare.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Walker RT, Woodyer AB, Dormandy JA. Venous claudication. A report of 15 cases and a review of the literature. Int Angiol 1985; 4:365–367.
Kontos HA. Arteriosclerosis obliterans. Cecil Textbook of Medicine, 20th ed. Bennett/Plum, 1996, pp. 350–351.
Anstrom SM, El-Hayek A, Comianos M, Tamulouis DJ. Mitral valve disease associated with long-term ergotamine use. Southern Med J 1993;86:1179–1181.
Ouriel K, Green RM. Arterial disease. In: Schwartz S, ed. Principles of Surgery, 7th ed. New York: McGraw-Hill Health Professions Division, 1999, p. 981.
Waal Manning HJ. Hypertension: which beta-blocker? Drugs 1976; 12:412–441.
Radack K Deck C. β-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. Arch Int Med 1991; 151:1769–1776.
Lepautelo M. Beta-blockade and intermittent claudication. ActaMed Scand 1985; 700:Sl–S48.
Friedman SA, Pandya M, Grief E. Peripheral arterial occlusion in patients with acute coronary heart disease. Am Ht J 1973; 86:415.
Barnhorst DA, Barner HB. Prevalence of congenitally absent pedal pulses. NEngl JMed 1968; 278:264.
Stephens G. Palpable dorsalis pedis and posterior tibial pulses. Arch Surg 1962; 84:662.
Friedman SA. Prevalence of palpable wrist pulses. Br Ht J 1970; 32:316.
Juergens JL, Barker NW, Itines EA. Review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 1960; 21:188–195.
Arnold AM. Chest pain in a patient with congenital heart disease. Cleveland Cl J Med 1995; 62:206–208.
Wynne J. Miscellaneous conditions of the heart: tumor, trauma and systemic disease. In: Cecil Textbook of Medicine, 20th ed. Bennett/Plum, 1996, pp. 357–359.
Hinton RC, Kistler JP, Callan JT, et al. Influence of etiology of atrialfibrillation a incidence of systemic embolism. Am J Cardiology 1977; 40:509.
Lord JW Jr, Rossi G, Daliana M, Drago JR, Schwartz M. Unsuspected aneurysm as a cause of peripheral arterial occlusive disease. Am Surg 1973; 177:767–771.
Hans SS, Zesking HJ. Routine use of limited abdominal aortography with digital subtraction cardiac and cerebral angiography. Stroke 1995; 26:1221–1224.
Leng GC, Fowkes FGR. The Ediburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992; 45:1101–1109.
Lepautello M, Lassila R. Smoking and occlusive peripheral arterial disease. Clinical review. Eur J Surg 1991; 157:83–87.
Hratt WR, Regeusteiner JG, Hargarten ME, Wollel EE, Brass EP. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990; 81:602–609.
Lowe GD, SaniaPadi A, Turner A, Lieberman P, Pollock J, Drury J. Strides on hematocrit in peripheral arterial disease. Klin Wochenschr 1986; 64:969–976.
Siitonen O, Vusitupa M, Pyorala K, Voutilainen E, Lansimies E. Peripheral arterial disease and its relationship to cardiovascular risk factors and coronary artery disease in newly diagnosed non-insulin dependent diabetes mellitus. Act Med Scand 1986; 220:205–212.
Radack K, Wyderski RJ. Conservative management of intermittent claudication. Ann Intern Med 1990; 113:135–146.
Balkau B, Vray M, Eschewege E. Epidemiology of peripheral arterial disease (Review). J Cardiovasc Pharmacol 1994; 23:S8–S16.
Deary IJ, Fowkes FG, Dannan PT, Housley E. Hostile personality and risk of arterial disease in the general population. Psychosis Med 1994; 56:197–202.
Brand FN, Abbott RD, Kannel WB. Diabetes, intermittent claudication and risk of cardiovascular events. The Framingham Study. Diabetes 1989;38:504–509.
Pomrehn P, Duncan B, Weissfeld L, Wallace RB, Barnes R, Heiss G, et al. The associationof dyslipoproteinemias with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study. Circulation 1986; 73:1100–1107.
Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication. The Framingham Study. J Am Geriatr Soc 1985; 33:13–18.
Horby J, Grande P, Vestergaard A, Grauholt AM. High-density lipoprotein cholesterol and arteriography in intermittent claudication. Eur J Vase Surg 1989; 3:333–337.
Myers KA. Relationship of smoking to peripheral arterial disease. Australian Family Physician 1979; 8:765–768.
Lowe GD, Fowkes FG, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen and activation of coagulation and leucocyte in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993; 87:1915–1920.
Gagnan F, Dagenais GR, Robitailde NM, Lupien PJ. Impact of systolic and dias-tolic blood pressure on ischemic vascular diseases in French-Canadian men from 1974 to 1990. Can J Cardiol 1994; 10:97–105.
Criqui MH, Frouek A, Klauber MR, Barrett-Connor E, Gabriel S. The sensitivity, specificity and predictive value of traditional clinical evaluation of peripheral arterial disease: results for non-invasive testing in a defined population. Circulation 1985; 71:516–522.
McDaniel MD, Cronnerwett JL. Basic data related to the natural history of intermittent claudication. Ann Vase Surg 1989; 3:273–277.
Fowkes FG, Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ. Edinburgh Artery Study: Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991; 20:384–392.
Mahmoud AH. A population sample study of peripheral occlusive arterial disease. Thesis, Univ. of Michigan, Ann Arbor, Michigan, 1964.
Jonason T, Ringquist I. Diabetes mellitus and intermittent claudication. Relation between peripheral vascular complications and location of occlusive atherosclerosis of the legs. Ada Med Scand 1985; 218:217–221.
Caralis DG. Assessing perioperative cardiac risk in peripheral arterial diseases. Balas’s har. Hell Vase Surg Soc Athens, 1993;l:21–27.
Hertzer NB, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Sur 1984; 199:223.
Mautner GC, Maunter SL, Roberts WC. Amounts of coronary arterial narrowing by atherosclerotic plaque at necropsy in patients with lower extremity amputation. Am J Cardiol 1992; 70:1147.
Mautner GC, Berezowski K, Mautner SL, Robert WC. Degrees of coronary arterial narrowing at necropsy in with large fusiformis abdominal aortic aneurysms. Am J Cardiology 1992; 70:1143.
Stevenow L, Karlsson S, Lilia B, Lindgarde F. High prevalence of coronary heart disease in patients with intermittent claudication. Ada Chir Scand 1988; 154:447–451.
Hunt JR. The role of the carotid arteries in the causation of vascular lesions of the brain, with remarks on certain special features of the symptomatology. Am J Med Sci 1914; 147:704.
Dean RH. Carotid artery occlusive disease. In: Sabiston, Textbook of Surgery, 14th ed. Philadelphia: W.B. Saunders, 1991, pp. 1580–1583.
Lassila R, Lepantelo M, Lindfors O. Peripheral arterial disease. Natural outcome. Ada Med Scand 1986; 220:295–301.
Ohta T, Kato T, Kazui H, Koudo M, Tsuchioka H, Shionoya S. The prognosis of intermittent claudication. (Jap) Nippon Geka Gakka Zasschi 1989;90:615–621.
Juergens JL, Barker NW, Hines CA. Arteriosclerosis obliterans review of 520 cases with special reference to pathogenic and prognostic factors. Circulation 1960; 21:188–195.
Imperato AM, Kiu GE, Davidson T, Crowley JG. Intermittent claudication. Its natural course. Surgery 1975; 78:795–799.
Schadt DC, Hines EA Jr, Juergens JL, Barker NW. Chronic atherosclerotic occlusion of the femoral artery. J Angio 1961; 175:937–940.
Criqui MH, Langer RD, Frouck A, Feigelson HS, Klauber MR, McCann TJ, Browner D. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326:301–306.
Spittell JA Jr. Occlusive peripheral arterial disease. Guidelines for office management. Postgrad Med 1982; 71:137–142,146,150–151.
Postiglione A, Cicerano V, Gallotta G, Chasso A, Lamenza F, Rubba P, Manciui M. Prevalence of peripheral arterial disease and related risk factors in elderly institutionalized subjects. Gerontology 1992; 38:330–337.
Laing SP, Greenhalgh RM. Standard exercise test to assess peripheral arterial disease. Br Med J 1980; 280:13–16.
Belcaro G, Sager P, Borgwardt A, Holm A, Jelnes R, Rosenkvist L, Possati F. Arterial pressure measurements correlated to symptoms and signs of peripheral arterial disease. Ada Chir Belgrca 1983;83: 320–326.
Lee BY, Trainor FS, Thoden WR, Kavner D, Madden JL. Use of non-invasive electromagnetic flowmetry in the assessment of peripheral arterial disease. Surg Gynecol Obst 1980; 150:342–346.
Seder JS, Botvinich EM, Rahimtooda SH, Goldstone J. Price DC. Detecting and localizing peripheral arterial disease: assessment of (201)T1 scrutigraphy. AJR Am J Roentgenol 1981;137:373–380.
Lie JT. Thromboangiitis obliterans (Buerger’s disease) revisited. Pathol Anna 1988; 23:257.
Wheeler HB. Thromboangiitis obliterans (Buerger’s disease). In: Sabiston, Textbook of Surgery, 14th ed. Townsend CM, ed. Philadelphia: W.B. Saunders, 1991, pp. 1637–1640.
McKusick VA, Harris WS, Ottesea OE, et al. Buerger’s disease. A distinct clinical and pathologic entity. JAMA 1962;181–185.
Adar R, Papa MZ, Halpern Z, et al. Cellular sensitivity to collagen in thromboangrtis obliterans. N Engl J Med 1983; 308:1113.
Caralis DG, et al. Smoking is a risk factor for coronary spasm in premenopausal women. Circulation 1992;85:905–909.
Collis PS, Mc Donald PT, Lim RC. Popliteal artery entrapment: an evolving syndrome. J Vase Surg 1989; 10:484–490.
Barnett AJ, Dugdale L, Fergresan I. Disappearing pulse syndrome due to myxoma-tous degeneration of the popliteal artery. Med J Austral 1966; 2:355–358.
DeWeese JA. Pedal pulses disappearing with exercise. N Engl J Med 1960;262:1214–1217.
Ishikawa K. Cystic adventitial disease of the popliteal artery and of other stem vessels in the extremities. Jpr J Surg 1987; 17:221–229.
Seddan AM. Popliteal artery aneurysms. Postgrad Med 1993; 94:125–128.
Dale WA. Thoracic outlet compression syndrome; critique. Arch Surg 1982; 117:1437.
Harding A, Silver D. Thoracic outlet syndrome. In: Sabistan, Textbook of Surgery, 14th ed. Townsend CM, ed. Philadelphia: W.B. Saunders, 1991, pp. 1757–1761.
Parachuri R, Adaues EM. Entrapment neuropathies. Postgrad Med 1993; 94:39–51. (Thoracic outlet syndrome in p. 45.)
Takayasu M. Case of queer changes in central blood vessels of the retina. Ada Soc Optham Jap 1908; 12:2554.
Ishikawa K. Natural history and classification of occlusive thomboartopathy (Takayasui’s disease). Circulation 1978; 51:21.
Snyder EN Jr, Mulfinoer GL, Lambert RW. Claudication caused by compression of the cauda equine. Am J Surg 1975; 130:172.
Goodreau JJ, Creasy JK, Flanigan DP, Burnham SF, Kudina JC, Schafter MF, et al. Rational approach to the differentiation of vascular and neurogenic claudication. Surgery 1978; 84:749–757.
Evans JG. Neurogenic intermittent claudication. Br Med J 1964; 2:985.
Wilson CB, Ebni G, Grollnus J. Neurogenic intermittent claudication. Cl Neurosurg 1971; 18:62.
Karayannakos PE, Yahou D, Vasco JS. Narrow lumbar spinal canal with “vascular” syndromes. Arch Surg 1976; 111:803.
Karanaugh GJ, Svein HJ, Holman CB, Johnson RM. Pseudoclaudication syndrome produced by compression of the cauda equine. JAMA 1968; 206:2477–2481.
Malis LI. Lumbar stenosis. Mt Sin J Med 1991; 58:121–124.
Gaskill MF, Lukin R, Wiot JC. Lumbar spine disease and stenosis. Radiol ClNorth Am 1991; 29:753–764.
Harats N, et al. Spinal claudication in systemic amyloidosis. J Rheumatol 1989; 16:1003–1006.
Drouillard PJ, et al. Lumbar spinal ateliosis associated with hypertrophied liga-mentum flavum and calcium pyrophosphate crystal deposition. Am Osepopath Assoc 1988; 88:1019–1021.
Sutton D, ed. A Textbook of Radiology and Imaging. 4th ed. New York: Edinburgh 1987.
Hammerschlag SB, Wolpert SM, Carter BL. Computed tomography of the spinal cord. Radiology 1976; 121:361.
Wipf JE, Deyo RA. Low black pain. Med Cl North Am 1995; 79:231–246.
Hines EA. Some types of distress in the lower extremities similating peripheral vascular disease. Med Cl North Am 1958; 42:991–996.
Brish A, Lerner MK, Braham J. Intermittent’ claudication from compression of the cauda equina by a narrowed spinal canal. J Neurosurg 1964; 21:207–211.
Wilson CB. Significance of the small lumbar spinal canal. Cauda equina compression syndromes due to spondylosis. J Neurosurg 1969; 31:499–506.
Blau JN, Logue V. Intermittent claudication of the cauda equina. Lancet 1961; 1:1081–1086.
Blau JN, Rushworth G. Observations in the blood vessels of the spinal cord and their responses to motor activity. Brain 1958; 81:354–363.
Cooke TD, Lehmann PO. Intermittent claudication of neurogenic origin. Can. J Surg 1968; 11:151–159.
Raynaud M. On local asphyxia and symmetrical changes of the extremities. Selected monograph. London. New Sydenham Society, 1888.
Allen EV, Brown EG. Raynaud’s disease. A critical review of minimal requisites for diagnosis. Am J Med Sci 1932; 183:187–200.
de Takats G, Fowler EF. Raynaud’s phenomenon. JAMA 1962; 179:88–106.
Blunt RJ, Porter JM. Raynaud’s syndrome. Semin Arthritis Rheum 1981; 10:282.
Porter JM, Bardana EJ, Baur GM, Wesche DH, et al. The clinical significance of Raynaud’s syndrome. Surgery 1976; 80:756.
Joyce JW. Raynaud’s phenomenon. In: Hurst’s the heart:arteries and veins. 8th ed., Schlant KC, Alexander RW, eds. New York: McGraw-Hill, 1994, pp. 2189–2190.
Porter JM, Snider RL, Bardana EJ, et al. The diagnosis and treatment Raynaud’s phenomenon. Surgery 1975; 77:11.
Taylor W, Pelmear PL. Raynaud’s phenomenon of occupational origin. An epide-miological survey. Ada Chir Scand 1976; 465:27.
Kontos HA. Vascular diseases of the limbs. In: Cecil Textbook of Medicine, 20th ed. Bennet/Plum 1996, pp. 346–350.
Gifford RW Jr, Hines EA Jr. Raynaud’s disease among women and girls. Circulation 1957; 16:1012.
Lewis T. Experiments relating to the peripheral mechanisms involved in spastic arrest of the circulation in the fingers, a variety of Raynaud’s disease. Heart 1929; 15:7.
Edwards JM, Phinney ES, Taylor IMJr, Kennan EJ, Porter JM. Alpha-2 adreno-ceptor differences in vasospastic and obstructive Raynaud’s syndrome. J Vase Surg 1987; 5:38.
Marsden PA, Danthuluri NR, Brenner BM, Ballerman BJ, Brock TA. Endothedin action on vascular smooth muscle involves inositol triphosphate and calcium mobilization. Biochem Biphys Res Commun 1988; 158:86–93.
Luscher TF, Yang Z, Diederich D, Buhler FR. Endothelium-derived vasoactive substance. Potential role in hypertension, atherosclerosis and vascular occlusion. J Cardiovasc Pharmacol 1989; 14:563–569.
Vane JR, Botting R, Masaki T. Endothelin. J Cardiovasc Pharmacol 1989; 13: S1–S231.
Luscher TF, Boulanger CM, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hypertension 1992; 19:117–130.
McMillen M.A., Sumpio B.E.: Endotherlins: Polyfunctional Cytokines. J. Am. Coll. of Surgeons 1995; 180:621–637.
Levin ER. Mechanisms of disease: Endotherlins. N Engl J Med 1995;333:356–363.
Roald OK, Sean E. Treatment of Raynaud’s phenomenon with ketanserin in patients with connective tissue disorders. Br Med J 1984;289:577–579.
Kahan A, Weber S, Amor B, et al: Nifediprue and Raynaud’s phenomenon (letter). Ann Int Med 1981; 94:546.
Smith DC, McKendry RJ. Controlled trial of Nifedipine in the treatment of Raynaud’s phenomenon. Lancet 1982; 2:1299.
Stone PH, Autman EJ, Mueller JE. Calcium channel blocking agents in the treatment of cardiovascular disorders. PartII. Hemodynamic effects and clinical application. Am Int Med 1980; 93:886.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Caralis, D.G. (2005). Claudication. In: Caralis, D.G., Bakris, G.L. (eds) Lower Extremity Arterial Disease. Clinical Hypertension and Vascular Diseases. Humana Press. https://doi.org/10.1385/1-59259-881-1:001
Download citation
DOI: https://doi.org/10.1385/1-59259-881-1:001
Publisher Name: Humana Press
Print ISBN: 978-1-58829-554-5
Online ISBN: 978-1-59259-881-6
eBook Packages: MedicineMedicine (R0)